Skip to main content
PureTech Health plc logo

PureTech Health plc — Investor Relations & Filings

Ticker · PRTC ISIN · GB00BPVG5C82 LEI · 213800LVPDNO2Z9T9I39 IL Manufacturing
Open in API
Filings indexed 1,319 across all filing types
Latest filing 2023-11-22 Transaction in Own Shar…
Country GB United Kingdom
Listing IL PRTC

About PureTech Health plc

https://puretechhealth.com/

PureTech Health is a clinical-stage biotherapeutics company dedicated to discovering, developing, and commercializing new classes of medicine for devastating diseases. The company's research and development engine focuses on advancing novel treatments by enhancing on-target efficacy, improving tolerability, or enabling oral administration of therapeutics with validated mechanisms. Its pipeline includes wholly-owned therapeutic candidates targeting a range of conditions, including idiopathic pulmonary fibrosis, neuropsychiatric disorders, and various cancers.

Recent filings

Filing Released Lang Actions
Transaction in Own Shares
Transaction in Own Shares Classification · 100% confidence The document explicitly states its purpose in the title section: 'Transaction in Own Shares'. It details the purchase of ordinary shares as part of a 'Share Buyback Programme' on a specific date (21 November 2023), including volume, highest, lowest, and VWAP prices. This directly corresponds to the definition of 'Transaction in Own Shares' (Code: POS), which covers share repurchase activities. The RNS Number and LSE/FCA context confirm it is a regulatory disclosure, but the content is highly specific to share transactions.
2023-11-22 English
Transaction in Own Shares
Transaction in Own Shares Classification · 100% confidence The document explicitly states its purpose in the title: "Transaction in Own Shares". It details the purchase of ordinary shares as part of a "Share Buyback Programme" on a specific date (20 November 2023), including volume, high, low, and VWAP prices. This directly corresponds to the definition of a Transaction in Own Shares (Share Repurchase/Issuance). The filing is also marked with the RNS Number and mentions compliance with MAR, typical for such regulatory disclosures. Therefore, the correct classification is POS.
2023-11-21 English
Transaction in Own Shares
Transaction in Own Shares Classification · 100% confidence The document explicitly states its purpose in the title section: 'Transaction in Own Shares'. It details the purchase of ordinary shares as part of a 'Share Buyback Programme' on a specific date (17 November 2023), including volume, high, low, and VWAP prices. This directly corresponds to the definition of 'Transaction in Own Shares' (Code: POS), which covers share repurchase/issuance activities. The RNS number and LSE context confirm it is a regulatory disclosure, but the content is highly specific to share transactions.
2023-11-20 English
Karuna's Blood Pressure Trial of KarXT Successful
Regulatory Filings Classification · 98% confidence The document begins with an RNS Number (7677T) and is dated November 17, 2023. It reports on positive clinical trial results for a drug (KarXT) developed by a Founded Entity (Karuna Therapeutics) of the reporting company (PureTech Health PLC). The text is structured as a press release announcing a specific corporate/scientific development, including key data points and forward-looking statements, and it explicitly mentions being provided by 'Reach, the non-regulatory press release distribution service of RNS, part of the London Stock Exchange.' This format strongly indicates a general regulatory announcement or press release distributed via the RNS system, which aligns best with the 'Regulatory Filings' (RNS) category, as it is not a full financial report (10-K, IR), an earnings release (ER), or a specific management/board change announcement.
2023-11-17 English
Transaction in Own Shares
Transaction in Own Shares Classification · 100% confidence The document explicitly states the subject is a 'Transaction in Own Shares' and details the purchase of ordinary shares as part of a 'Share Buyback Programme'. It provides specific transaction dates, volumes, and prices, and concludes with the updated total shares in treasury and shares in issue. This directly corresponds to the definition of 'Transaction in Own Shares', which maps to the filing code POS (Report of the company buying back or selling its own shares (share repurchase/issuance)). The presence of the RNS Number and the LSE/FCA context confirms it is a regulatory disclosure, but the content is specific enough to use the dedicated POS code.
2023-11-17 English
Transaction in Own Shares
Transaction in Own Shares Classification · 100% confidence The document explicitly announces a 'Transaction in Own Shares' as part of a 'Share Buyback Programme'. It details the number of shares purchased, the prices paid, and the resulting treasury share balance. This directly corresponds to the definition of 'Transaction in Own Shares' (Code: POS). The presence of the RNS Number and the reference to the London Stock Exchange confirms it is a regulatory disclosure, but the specific content points overwhelmingly to POS.
2023-11-15 English

Browse filings by year

12 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.